ICL questions, answered plainly

An ICL is a soft, permanent implant, much smaller than a contact lens, placed inside the eye, behind the colored iris and in front of your natural lens, to correct nearsightedness and astigmatism. Once it’s in, you never take it out or clean it, you can’t feel it, and no one can see it. Unlike LASIK, no corneal tissue is removed, and the lens can be removed later if needed.

Collamer is a soft, flexible biomaterial made of collagen blended with a water-loving polymer. Because it contains collagen, it attracts a thin layer of fibronectin, a natural protein already in your eye’s fluid, which coats the lens and effectively hides it from your immune system, so it sits quietly inside the eye with minimal inflammation. It’s also highly transparent and carries a built-in UV filter.

Read the full guide →

Yes. Collamer carries a built-in UV-absorbing filter, a property of the material itself, not a coating that can wear off. The important limit: the lens sits behind the iris, so it filters UV heading to the back of the eye and does nothing for your cornea, eyelids or surrounding skin. It is not a replacement for sunglasses.

Read the full guide →

There’s a sound mechanistic argument, but no proof. Cumulative UV exposure is an established risk factor for cortical cataract, and the ICL sits directly in front of your natural crystalline lens, filtering UV before it arrives, so in principle it lowers that lens’s lifetime UV dose. No study has shown that having an ICL reduces cataract risk, and proving it would take decades of follow-up. Treat it as a plausible bonus, not a reason to choose the procedure.

Read the full guide →

Partly, as a second layer rather than first-line protection. In an eye that still has its natural lens, that lens already absorbs most UV before it reaches the retina, so the ICL adds redundancy. UV and high-energy visible light have been linked to retinal and macular ageing, but that evidence is debated. The ICL’s more plausible benefit is to the crystalline lens sitting right behind it.

Read the full guide →

No. When surgeons remove an ICL during cataract surgery many years or even decades after it was implanted, they typically find it essentially unchanged, still clear, still soft and flexible, with no clouding, yellowing, surface deposits or calcification. The fibronectin coat that forms early on keeps proteins and cells from accumulating on it, and unlike a contact lens it’s never exposed to air, tears, handling or cleaning solutions.

Read the full guide →

The surgery itself takes about 5 to 10 minutes per eye. Counting preparation, dilation and the time you are actually in the operating suite, most patients are there for roughly 20 to 30 minutes, which is why you will see both numbers quoted. Both eyes are typically done the same day, and you are awake throughout with numbing drops rather than a general anaesthetic.

LASIK, PRK, and SMILE reshape the cornea by removing tissue. ICL adds a lens inside the eye and removes no corneal tissue, so it’s often preferred for high prescriptions, thin corneas, or dry-eye-prone patients. Because it doesn’t change your eye’s anatomy, it just adds a lens, it’s often considered the least invasive form of vision correction, and it’s reversible: the lens can be removed or exchanged later.

Often, yes, especially for high prescriptions. Glasses sit away from the eye and shrink the image (the “minification” effect), by very roughly 1–2% per diopter. The ICL sits inside the eye, close to the eye’s nodal point, the optical reference point that governs how large an image lands on your retina, so it projects a larger, more true-to-life image. Many highly nearsighted patients see sharper than they ever did in glasses.

Read the full guide →

The nodal points are optical reference points inside your eye, sitting near the back of your natural lens, about 7 mm behind the cornea. They determine how big the image projected onto your retina is. Because the ICL is implanted inside the eye, it corrects your vision far closer to the nodal point than glasses can, which is why the retinal image stays close to normal size rather than being shrunk. Strictly, the ICL sits in front of your natural lens rather than exactly at the nodal point, so “at the nodal point” is shorthand, but the optical advantage behind the phrase is real.

Read the full guide →

You’re kept comfortable with light oral medication (no IV is needed), and the eye is numbed with drops and held open so you can’t blink. The surgeon makes one or two tiny (~3 mm) self-sealing openings in the cornea, injects a protective gel, then inserts the folded lens, which unfolds and is gently tucked behind the iris in front of your natural lens. The gel is rinsed out and the opening seals itself. The surgery itself is usually about 5–10 minutes per eye, with no stitches, and both eyes are typically done the same day. Counting preparation and dilation, most patients are in the operating suite for roughly 20–30 minutes, which is why you will see both figures quoted.

You may be a good candidate if you’re a nearsighted adult (with or without astigmatism) with a stable prescription and no cataract. ICL is a first-choice procedure across its approved range, not just a fallback for people turned down for LASIK, many patients choose it on its own merits, because it preserves corneal tissue, leaves the tear film largely undisturbed and is removable. It’s especially helpful for active lifestyles, for people with allergies or dry eye who struggle with contact lenses, and it remains available when thin corneas or a high prescription rule laser out. A full evaluation confirms whether it’s the best fit for your eyes.

The US FDA labeling splits the range in two. For spherical equivalent from −3.0 D up to −15.0 D the EVO ICL is indicated for the correction of myopia; from beyond −15.0 D to −20.0 D it is indicated for the reduction of myopia, meaning the goal is to bring a very high prescription down rather than necessarily eliminate it. The toric (TICL) version covers cylinder from 1.0 D to 4.0 D across both bands; the non-toric lens is indicated for eyes with 2.5 D of astigmatism or less. Beyond −20 D, an ICL can reduce the nearsightedness into a range LASIK or PRK can finish, a staged combination called bioptics.

It is a meaningful distinction about expectations. Up to −15.0 D the FDA labeling says the lens is for the correction of myopia: the aim is to eliminate the prescription. Beyond −15.0 D and out to −20.0 D it says reduction: the aim is to bring a very high prescription down substantially, and a small residual prescription afterwards is an anticipated outcome rather than a complication. If you are past −15 D, it is worth asking your surgeon directly what residual refraction they are planning for.

The FDA labeling asks for a stable refractive history within 0.5 D for the year before implantation (for the toric lens, within 0.5 D for both spherical equivalent and cylinder). That is why surgeons ask for older glasses or contact lens prescriptions, and why patients in their late teens and early twenties are often asked to wait: implanting against a prescription that is still moving means the correction drifts.

Very high prescriptions (−8 D and beyond) are actually where ICL shines, because correcting them with laser would remove too much corneal tissue. High myopes are among the best ICL candidates. The lens keeps excellent optical quality even at extreme prescriptions, often delivering sharper vision than glasses could.

The FDA labeling requires an ACD of 3.00 mm or greater, measured from the corneal endothelium to the front of your natural lens, and lists a true ACD below 3.00 mm as a contraindication. Deeper is better, because it leaves more room for the lens. Surgery below 3.00 mm is done off-label by some experienced surgeons, and published outcomes in eyes under 3.00 mm have been good when sizing is done carefully, but the margin for error is smaller, which makes precise sizing even more important.

There are two measurements: from the inside of the cornea to the lens (often labeled AQD) and from the outside of the cornea to the lens. The inside (AQD) value is the one that matters for ICL. The cornea is ~0.5 mm thick, which explains the difference between the two readings.

The endothelium is a non-regenerating cell layer that keeps the cornea clear. the FDA labeling sets a minimum cell density that depends on your age and your anterior chamber depth, not a single cutoff. Because younger eyes have to last longer, the requirement is highest for the youngest patients: roughly 3,875 cells/mm² at ages 21 to 25 with an ACD of 3.0 mm, easing to about 2,075 cells/mm² over age 45. Not meeting the minimum is a contraindication. Most healthy eyes comfortably exceed it, and specular microscopy at your evaluation measures it directly, so it is a number to ask about rather than assume.

Often yes, if your prescription is stable and you see well in glasses or soft contacts (meaning your astigmatism is “regular”). ICL preserves corneal tissue, so it’s gentler than laser. If the keratoconus is still progressing, corneal cross-linking (CXL) is usually done first.

Frequently, yes. Because ICL doesn’t reshape or thin the cornea, it stays available when thin or steep corneas rule laser out, and corneal preservation is a genuine reason to prefer it, not just a consolation prize.

ICL is often the gentler choice for dry-eye-prone patients because it doesn’t involve reshaping the cornea, so it doesn’t disrupt the corneal nerves or tear production the way a LASIK flap can. It isn’t a cure for dry eye, and there’s some temporary dryness early on, but it tends to have less long-term impact on the tear film. Many people find their dry-eye symptoms actually improve afterward, since they’re no longer wearing a contact lens every day.

Larger pupils can mean more night-time halos, but most people neuro-adapt over weeks to months. For larger pupils, surgeons may choose the EVO+ lens, which has a wider optic. Discuss your measured pupil size with your surgeon.

The EVO ICL is FDA-approved for adults 21–60, the FDA expanded the upper age limit from 45 to 60 in February 2026, and many surgeons also treat carefully selected patients from about 18 based on eye health and a stable prescription. Younger patients need documented prescription stability; older patients remain candidates as long as they haven’t yet developed a cataract.

Often yes. Because the ICL is added inside the eye and doesn’t touch the cornea, it can correct leftover or regressed prescription after prior laser surgery, and it’s an option when the cornea is now too thin for more laser. Your surgeon confirms suitability from your current measurements.

Stay out of contact lenses before your evaluation so the cornea returns to its natural shape and the measurements are accurate, commonly about 5 days for soft lenses and 3 weeks for rigid (gas-permeable) lenses. Tell the clinic in advance if you wear specialty or hard lenses. With enough advance planning, some practices can even perform the surgery the same day as your consultation.

Vault is the tiny gap between the back of the ICL and your natural lens. There’s no single “correct” number, it varies from eye to eye and even shifts as your pupil changes with light. What matters is a lens that fits your eye and avoids extremes; today’s EVO lenses tolerate a wide range, including low vaults.

The lens must match the internal width of your eye where it sits (the sulcus). The most accurate approach today measures that space with ultrasound (UBM) or OCT and feeds it into a machine-learning calculator that predicts the vault for each size, the approach behind ICLFit.com, rather than estimating from the cornea’s white-to-white width alone.

A very low vault is usually just observed (EVO tolerates it well). A too-high vault can narrow the drainage angle and raise pressure; if needed, the ICL is exchanged for a smaller size or rotated to reduce the vault. These adjustments are uncommon, especially when sizing is done carefully.

It’s uncommon, and it’s the main reason sizing accuracy matters so much. Most exchanges are sizing-related (a smaller share are toric-lens rotations). Better measurement and AI vault prediction are specifically aimed at lowering this rate.

A toric ICL has the astigmatism correction built in and must be rotated to line up precisely with your eye’s astigmatism axis. Surgeons mark the axis while you’re sitting up (to account for slight eye rotation when lying down) and align the lens during surgery.

The toric ICL corrects from about 1.0 D up to 4.0 D in the US (6.0 D in some countries). Those figures are measured at the spectacle plane, meaning the numbers on your glasses prescription. Around 0.50 D or less usually is not worth correcting, because it rarely affects vision.

Around 0.75 D and up, most surgeons use a toric lens because that amount can blur vision. About 0.50 D or less is usually not worth correcting because it rarely affects vision.

Yes, it’s common and not a problem to use a toric ICL in the eye with astigmatism and a standard ICL in the other.

A toric ICL gives a more predictable, stable correction. LRIs (limbal relaxing incisions) can help with small amounts but are less reliable, can regress over a few years, and rarely create irregular astigmatism. Most surgeons now prefer a toric ICL when astigmatism needs correcting.

ICL surgery is considered very safe, but like any eye surgery it carries some remote risks: infection, inflammation, glare or halos, a temporary rise in eye pressure, and, rarely, damage to the eye. Occasionally the lens needs to be adjusted or exchanged if the fit or power isn’t optimal. The modern EVO lens lets fluid flow freely through a central port, which has greatly reduced the cataract and pressure-spike risks seen with older-generation lenses. The categories below cover each of these in more detail.

This was a genuine concern with the older, non-ported ICL. The current EVO ICL has a central port that lets fluid flow freely to nourish the natural lens, and that single design change has made ICL-related cataract very rare in modern practice. Cataracts from aging or other causes can still occur, as they would anyway.

Read the full guide →

The EVO has a tiny central hole (KS-AquaPORT) that keeps the eye’s natural fluid flowing around your lens. That single design change largely eliminated the old cataract risk and removed the need for a separate laser hole in the iris.

Rotation is rare, large studies show repositioning is needed in under 0.5% of cases. It’s mostly driven by an undersized lens (too little vault), so good sizing is the best prevention. If it does rotate, the lens can be turned back into position or exchanged for a larger size.

Read the full guide →

Very rarely, about 0.07%, and essentially only after blunt trauma directly to the eye (like a ball or elbow during sports). A dislocated ICL can be repositioned, and in studies those patients did not lose vision.

A mild, temporary pressure rise can happen early on, usually from leftover protective gel, the steroid eye drops, or a high vault, and is easily managed, often resolving within a month or two. A too-high vault that keeps pressure up can be fixed by exchanging the lens for a smaller size.

No, long-term studies show ICL itself does not change retinal detachment risk. However, many ICL patients are highly nearsighted, and high myopia carries its own baseline retinal risk, so regular dilated eye exams remain important after surgery.

There’s no good evidence that ICL causes floaters. Highly nearsighted eyes are simply more prone to floaters in general, so any increase is usually related to the myopic eye rather than the surgery.

ICL causes a small initial dip in corneal endothelial cells (around 4%), after which loss returns close to the normal age-related rate. For healthy eyes with adequate cell counts, the lifetime effect is generally not clinically significant.

Read the full guide →

Normal activity is no concern. The rare risk (dislocation) needs a direct, forceful blow to the eye, so for contact sports it’s wise to use eye protection, advice that applies whether or not you have an ICL.

Light, incidental rubbing is very unlikely to do anything. Hard “knuckle-grinding” into the eye should be avoided, both because of the small theoretical pressure risk and because vigorous rubbing can weaken the cornea over time.

Most people see remarkably well within hours of sitting up, which is often the moment patients remember. Vision can look a little hazy at first while the dilation wears off, and the eye may feel slightly scratchy for a few hours. Both settle quickly, and most of it has cleared by the next morning.

Read the full guide →

ICL has a quick recovery, vision usually improves dramatically within the first day, and most normal activities resume within days. You’ll have follow-up checks (typically day 1, week 1, and month 1) to confirm pressure and lens position.

ICL corrects your distance vision. It does not change presbyopia, the normal age-related loss of near focus that affects everyone from the mid-40s onward, so if you already use reading glasses you will still use them, and if you do not, you should not expect ICL to change your near vision. For the right patient, the correction can be planned with a slight near bias in one eye to reduce reading-glasses dependence, which is worth asking your surgeon about.

Any dryness is usually mild and temporary, coming mostly from the preservative-containing post-op drops and the pre-surgery prep rather than from the procedure itself. It’s much milder than after LASIK and improves once the drops are finished; preservative-free artificial tears help in the meantime.

Read the full guide →

The EVO’s central port can create a faint ring in certain lighting, and the pupil dilating past the lens edge can cause halos. These effects are centered on your line of sight rather than blocking it, so they don’t interfere with your central vision, and most people stop noticing them as the brain adapts over weeks to months; bothersome, lasting cases are uncommon.

Travel is generally fine, many patients fly out the day after surgery. Just keep your follow-up visits, make sure you’ll have access to care, and bring preservative-free artificial tears since airplane cabins are very dry. Cabin pressure changes don’t harm the eye after ICL.

About a week, which is roughly how long the microscopic openings take to heal. During that first week, keep water and heavy sweat out of your eyes. Many surgeons suggest goggles for a little longer after that, simply to avoid irritation from pool or ocean water.

Light activity is fine right away; most surgeons advise about a week off strenuous exercise and heavy lifting. When traveling soon after, use rolling luggage and ask for help with overhead bins.

Read the full guide →

Most patients see 20/20 or better in the distance without glasses after ICL. It corrects your distance prescription, not the age-related loss of near focus (presbyopia), so people in their mid-40s and beyond may still use reading glasses for close work, the same as anyone that age. The ICL is flexible, though, for the right patient the correction can be planned (for example, a slight near bias in one eye) to reduce dependence on reading glasses.

ICL is an elective vision-correction procedure, so it’s usually not covered by insurance. Cost is typically a few thousand dollars per eye (commonly around $4,000–$5,000), varying by surgeon, region, and whether you need the toric (astigmatism) lens.

Yes, most practices offer financing or payment plans (often including interest-free / 0% options), and ICL is generally eligible for tax-advantaged FSA and HSA funds. Many patients weigh the one-time cost against years of ongoing glasses and contact-lens expense, viewing it as a long-term investment that pays for itself over time.

The ICL is removable, upgradable, and exchangeable. When removed, your eye returns essentially to its original prescription because the cornea was never altered, and the lens can be swapped for a new one if your prescription changes or the technology advances. It’s “removable” rather than perfectly “reversible,” since the microscopic openings add a tiny, usually insignificant amount of astigmatism.

A small residual prescription happens in roughly 1–2% of cases and is very treatable. Because it’s now a small amount, a LASIK or PRK “touch-up” is easy and accurate, even for people who weren’t laser candidates before, since little tissue is needed. Sometimes rotating or exchanging the ICL is the better fix.

No. Cataract measurements can be taken with the ICL in place, and the ICL is simply removed at the start of cataract surgery. Keeping the cornea untouched also preserves your options for advanced lens implants down the road.